Morimoto, Richard I.
- Northwestern University · Biochemistry (NIH department code)
From the FY2022 NIH awards this investigator leads as contact PI. The department is the award's.
FY2022 NIH rank #1,868
- Sustained Excellence
- Program Leader
- Long-Funded
- Top 10% Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2006 through FY2022Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2022 award categories
- Biochemistry
NIH Funding · FY2022
Linked Award Amount
$2.9M
Full award amounts, FY2022
Award Records
1
Records listing this PI
Award-Linked Rank
#1,868
By linked amount among FY2022 PIs
Earliest Year Loaded
2006
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2022 award records by amount
NIH award records listing Morimoto, Richard I. as a PI. Multi-PI records show the full award amount for context.
- 5P01AG054407-05P01Contact PIProteostasis in Aging and Neurodegenerative DiseaseNorthwestern University · Biochemistry (NIH department code)$2.9Maward amount
Award organization
Organizations that administered FY2022 awards listing Morimoto, Richard I. as a PI.
FY2022 award administered by Northwestern University (IL).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2006First NIH AwardNorthwestern University
- 2006$500K Cumulative Funding
- 2006$1M Cumulative Funding
- 2006Entered Top 50% NationallyRanked #4323
- 2006Entered Top 25% NationallyRanked #4323
- 2007$2M Cumulative Funding
- 2010$5M Cumulative Funding
- 2014Program/Center Grant Leader
- 2017$10M Cumulative Funding
- 2017Entered Top 10% NationallyRanked #1116
- 2020Entered Top 5% NationallyRanked #593
- 2022$25M Cumulative Funding